Article
Current progress in the treatment of chronic hepatitis C.
World journal of gastroenterology - 14 Nov 2012
Alexopoulou Alexandra, Papatheodoridis George V
Abstract excerpt
Over the last decade, the standard of care for the treatment of chronic hepatitis C has been the combination of pegylated-interferon-alfa (PEG-IFN) and ribavirin (RBV) which results in sustained virological response (SVR) rates of 75%-85% in patients with genotypes 2 or 3 but only of 40%-50% in p...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
